Danaher files $21 billion acquisition of GE BioPharma for EU review
Danaher has requested EU approval to buy GE BioPharma from General Electric. The European Commission has set a Dec. 4 deadline to decide on the deal.Danaher has requested EU approval to...To view the full article, register now.
Already a subscriber? Click here to view full article